Firms steer Everstone’s USD270m Apothecon investment

JSA and Khaitan & Co. have counselled on Singapore-headquartered Everstone Capital’s USD270 million investment in the drugmaker Apothecon Group, comprising India’s Apothecon Pharmaceuticals and US-based Navinta. DLA Piper, Troutman Pepper Locke and Brown & Connery also advised on the transaction. “It was a particularly engaging transaction given the various jurisdictions involved, and the counsel across jurisdictions (India, US, Mauritius). We have been involved in the transaction since its inception,” said Sidharrth Shankar, Partner, JSA Advocates & Solicitors.  Read more